New tumour markers for pancreatic cancer based on the altered glycosylation of serum glycoproteins 

Duran Sidera, Adrià (Date of defense: 2023-11-14)

Pancreatic cancer (PaC) is the deadliest of all tumours, with a 5-year survival below 12% and a mortality/incidence ratio of 94.5%. One of the main reasons behind this dismal prognosis is the diagnosis of the disease at ...